Daily BriefsSouth Korea

Daily Brief South Korea: LG Chem Ltd, HD Korea Shipbuilding & Offshore Engineering, LIVSMED, Nota and more

In today’s briefing:

  • Palliser Capital Goes Activist on LG Chem
  • Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps
  • LivsMed IPO Preview
  • Nota IPO Bookbuilding Analysis


Palliser Capital Goes Activist on LG Chem

By Douglas Kim

  • Palliser Capital started to go activist on LG Chem.  According to Palliser Capital, LG Chem’s share price is trading at a 74% discount to its NAV.
  • Palliser Capital proposed improving the composition of the board of directors, restructuring the executive compensation system to align with shareholder interests, and higher share buybacks. 
  • Our updated NAV analysis of LG Chem suggests implied price of 613,438 won per share, which represents a 57% higher levels than current levels.

Korea’s Next Policy Play: NAV Discount Squeeze on Low‑Float Large Caps

By Sanghyun Park

  • Market sniffing policy push; low-float names flagged as junk risk with skewed control. Desks circling, Palliser hit early—LG Chem trade popped, timing spot on.
  • Trade setup: screen >₩1tn caps with low float, parent stakes 60–80%. Policy push likely forces stake cuts, driving float higher and squeezing NAV discounts—LG Chem shows the play.
  • Screening >₩1tn caps flags 11 names: parents hold 60–80%. All potential stake-sale plays to boost float, squeeze NAV discount.

LivsMed IPO Preview

By Douglas Kim

  • LivsMed is getting ready to complete its IPO on the KOSDAQ exchange in December 2025. LivsMed is a medical device manufacturer that specialises in minimally invasive surgery products.
  • This is expected to be one of the largest IPOs in KOSDAQ in 2025.  The IPO price range is from 44,000 won to 55,000 won per share.
  • LivesMed has commercialized the world’s first multi-joint, multi-degree-of-freedom (DOF) technology capable of 90° rotation in all directions.

Nota IPO Bookbuilding Analysis

By Douglas Kim

  • Nota’s IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.
  • Our base case valuation of Nota suggests target price of 11,948 won per share, which is 31% higher than the IPO price (9,100 won). 
  • Nota Provides technology that enables the efficient operation of high-performance AI models even on resource-constrained edge devices, centered around its proprietary AI model optimization platform, NetsPresso®.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars